Adempas Tablets and Respiratory syncytial virus immune globulin, human Intravenous
Determining the interaction of Adempas Tablets and Respiratory syncytial virus immune globulin, human Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: riociguat
Brand name: Adempas
Synonyms: Riociguat
Generic Name: respiratory syncytial virus immune globulin
Brand name:
Synonyms: Respiratory syncytial virus immune globulin, human (Intravenous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Adempas Tablets-RespiVent Dosepack DF
- Adempas Tablets-Restall
- Adempas Tablets-Restoril
- Adempas Tablets-Retacrit
- Adempas Tablets-Retapamulin
- Adempas Tablets-Retapamulin topical
- Respiratory syncytial virus immune globulin, human Intravenous-Adenocard
- Respiratory syncytial virus immune globulin, human Intravenous-Adenoscan
- Respiratory syncytial virus immune globulin, human Intravenous-Adenosine
- Respiratory syncytial virus immune globulin, human Intravenous-Adenosine Intravenous
- Respiratory syncytial virus immune globulin, human Intravenous-Adenovirus Type 4 and Type 7 Vaccine Live Oral
- Respiratory syncytial virus immune globulin, human Intravenous-Adenovirus Vaccine